Alyeska Investment Group, L.P. - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 20 filers reported holding VASCULAR BIOGENICS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2020$107,000
-4.5%
83,3330.0%0.00%0.0%
Q1 2020$112,000
+12.0%
83,3330.0%0.00%
+100.0%
Q4 2019$100,000
-10.7%
83,3330.0%0.00%
-50.0%
Q3 2019$112,000
+3.7%
83,3330.0%0.00%
+100.0%
Q2 2019$108,000
-15.0%
83,3330.0%0.00%
-50.0%
Q1 2019$127,000
+56.8%
83,3330.0%0.00%
+100.0%
Q4 2018$81,000
-40.0%
83,3330.0%0.00%0.0%
Q3 2018$135,000
-26.2%
83,3330.0%0.00%
-50.0%
Q2 2018$183,000
-4.7%
83,3330.0%0.00%0.0%
Q1 2018$192,000
-67.6%
83,3330.0%0.00%
-60.0%
Q4 2017$592,000
+16.5%
83,3330.0%0.01%
+25.0%
Q3 2017$508,000
+36.9%
83,3330.0%0.00%
+33.3%
Q2 2017$371,000
-19.0%
83,3330.0%0.00%
-25.0%
Q1 2017$458,000
+13.4%
83,3330.0%0.00%
+33.3%
Q4 2016$404,000
-7.1%
83,3330.0%0.00%
-25.0%
Q3 2016$435,000
+13.3%
83,3330.0%0.00%0.0%
Q2 2016$384,000
+32.4%
83,3330.0%0.00%
+33.3%
Q1 2016$290,000
-33.8%
83,3330.0%0.00%
-40.0%
Q4 2015$438,00083,3330.01%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 92,000$189,0000.26%
Ikarian Capital, LLC 790,838$1,622,0000.11%
PVG ASSET MANAGEMENT CORP 12,365$25,348,0000.08%
Phoenix Holdings Ltd. 1,020,000$2,091,0000.04%
DAFNA Capital Management LLC 55,000$113,0000.03%
ARK Investment Management 1,393,460$2,857,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$163,0000.01%
Total Clarity Wealth Management, Inc. 4,000$8,0000.00%
Virtu Financial LLC 15,298$31,0000.00%
Altshuler Shaham Ltd 209,000$431,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders